Lucid Diagnostics (LUCD) EPS (Weighted Average and Diluted) (2022 - 2025)
Lucid Diagnostics (LUCD) reported EPS (Weighted Average and Diluted) of -$0.1 for Q3 2025, up 60.0% on a YoY basis from -$0.06 in Q3 2024, and down 25.0% quarter-over-quarter from -$0.08 in Q2 2025.
Lucid Diagnostics (LUCD) EPS (Weighted Average and Diluted) (2022 - 2025) Analysis & Trends
Lucid Diagnostics has reported EPS (Weighted Average and Diluted) for 4 years, with the latest figure at -$0.1 in Q3 2025.
- For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 60.0% year-over-year to -$0.1; the trailing twelve-month figure through Sep 2025 stood at -$0.88 (up 22.12% YoY), and the FY2024 full-year result was -$1.05, up 16.67% from the prior year.
- EPS (Weighted Average and Diluted) for Q3 2025 stood at -$0.1, down from -$0.08 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.08 in Q2 2025, with the low at -$0.52 in Q1 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.3 across 4 years, with a median of -$0.31 in 2023.
- The largest YoY upside for EPS (Weighted Average and Diluted) was 65.22% in 2025 against a maximum downside of 30.0% in 2025.
- Lucid Diagnostics' EPS (Weighted Average and Diluted) stood at -$0.4 in 2022, then jumped by 37.5% to -$0.25 in 2023, then gained by 28.0% to -$0.18 in 2024, then soared by 44.44% to -$0.1 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.1 (Q3 2025), -$0.08 (Q2 2025), and -$0.52 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Lucid Diagnostics | 149.20 Mn | 121.33 Mn | -325,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.10 |
| Jun 30, 2025 | -0.08 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | -0.18 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.23 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | -0.34 |
| Jun 30, 2023 | -0.27 |
| Mar 31, 2023 | -0.40 |
| Dec 31, 2022 | -0.40 |
| Sep 30, 2022 | -0.39 |
| Jun 30, 2022 | -0.41 |